A detailed history of Barclays PLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Barclays PLC holds 146,321 shares of PROK stock, worth $260,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146,321
Previous 146,321 -0.0%
Holding current value
$260,451
Previous $281,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$1.8 - $2.5 $224,400 - $311,667
124,667 Added 575.72%
146,321 $281,000
Q2 2024

Aug 14, 2024

SELL
$1.44 - $4.2 $14,317 - $41,760
-9,943 Reduced 31.47%
21,654 $54,000
Q1 2024

May 15, 2024

SELL
$1.2 - $1.76 $36,261 - $53,183
-30,218 Reduced 48.88%
31,597 $52,000
Q4 2023

Feb 15, 2024

BUY
$1.21 - $4.76 $58,363 - $229,593
48,234 Added 355.16%
61,815 $110,000
Q3 2023

Nov 07, 2023

SELL
$4.32 - $13.08 $18,403 - $55,720
-4,260 Reduced 23.88%
13,581 $63,000
Q2 2023

Aug 03, 2023

BUY
$9.0 - $13.0 $160,569 - $231,933
17,841 New
17,841 $200,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $110M
More about PROK
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.